These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 21605926

  • 21. In vivo trypanosomicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against acute and chronic phases of Chagas disease.
    Sánchez-Moreno M, Sanz AM, Gómez-Contreras F, Navarro P, Marín C, Ramírez-Macias I, Rosales MJ, Olmo F, Garcia-Aranda I, Campayo L, Cano C, Arrebola F, Yunta MJ.
    J Med Chem; 2011 Feb 24; 54(4):970-9. PubMed ID: 21229977
    [Abstract] [Full Text] [Related]

  • 22. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
    Cinque GM, Szajnman SH, Zhong L, Docampo R, Schvartzapel AJ, Rodriguez JB, Gros EG.
    J Med Chem; 1998 Apr 23; 41(9):1540-54. PubMed ID: 9554887
    [Abstract] [Full Text] [Related]

  • 23. ESR, electrochemical, molecular modeling and biological evaluation of 4-substituted and 1,4-disubstituted 7-nitroquinoxalin-2-ones as potential anti-Trypanosoma cruzi agents.
    Aguilera-Venegas B, Olea-Azar C, Norambuena E, Arán VJ, Mendizábal F, Lapier M, Maya JD, Kemmerling U, López-Muñoz R.
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Mar 23; 78(3):1004-12. PubMed ID: 21239218
    [Abstract] [Full Text] [Related]

  • 24. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
    Porcal W, Hernández P, Aguirre G, Boiani L, Boiani M, Merlino A, Ferreira A, Maio RD, Castro A, González M, Cerecetto H.
    Bioorg Med Chem; 2007 Apr 01; 15(7):2768-81. PubMed ID: 17287123
    [Abstract] [Full Text] [Related]

  • 25. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
    Boiani M, Piacenza L, Hernández P, Boiani L, Cerecetto H, González M, Denicola A.
    Biochem Pharmacol; 2010 Jun 15; 79(12):1736-45. PubMed ID: 20178775
    [Abstract] [Full Text] [Related]

  • 26. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
    Benítez J, Becco L, Correia I, Leal SM, Guiset H, Pessoa JC, Lorenzo J, Tanco S, Escobar P, Moreno V, Garat B, Gambino D.
    J Inorg Biochem; 2011 Feb 15; 105(2):303-12. PubMed ID: 21194632
    [Abstract] [Full Text] [Related]

  • 27. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
    Vieites M, Otero L, Santos D, Olea-Azar C, Norambuena E, Aguirre G, Cerecetto H, González M, Kemmerling U, Morello A, Diego Maya J, Gambino D.
    J Inorg Biochem; 2009 Mar 15; 103(3):411-8. PubMed ID: 19187969
    [Abstract] [Full Text] [Related]

  • 28. Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents.
    Jorge SD, Palace-Berl F, Mesquita Pasqualoto KF, Ishii M, Ferreira AK, Berra CM, Bosch RV, Maria DA, Tavares LC.
    Eur J Med Chem; 2013 Jun 15; 64():200-14. PubMed ID: 23644203
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.
    Singh PK, Jones MM, Lane JE, Nesset A, Zimmerman LJ, Ribeiro-Rodrigues R, Richter A, Stenger MR, Carter CE.
    Arzneimittelforschung; 1997 Mar 15; 47(3):311-5. PubMed ID: 9105552
    [Abstract] [Full Text] [Related]

  • 30. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC, Braga RC, Muratov EN, Franco CH, Moraes CB, Freitas-Junior LH, Andrade CH.
    Eur J Med Chem; 2019 Feb 01; 163():649-659. PubMed ID: 30562700
    [Abstract] [Full Text] [Related]

  • 31. Lead identification to clinical candidate selection: drugs for Chagas disease.
    Neitz RJ, Chen S, Supek F, Yeh V, Kellar D, Gut J, Bryant C, Gallardo-Godoy A, Molteni V, Roach SL, Khare S, Stinson M, Chatterjee AK, Robertson S, Renslo AR, Arkin M, Glynne R, McKerrow J, Siqueira-Neto JL.
    J Biomol Screen; 2015 Jan 01; 20(1):101-11. PubMed ID: 25281737
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
    Sánchez-Moreno M, Marín C, Navarro P, Lamarque L, García-España E, Miranda C, Huertas O, Olmo F, Gómez-Contreras F, Pitarch J, Arrebola F.
    J Med Chem; 2012 May 10; 55(9):4231-43. PubMed ID: 22443115
    [Abstract] [Full Text] [Related]

  • 33. On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions.
    da Silva Júnior EN, de Melo IM, Diogo EB, Costa VA, de Souza Filho JD, Valença WO, Camara CA, de Oliveira RN, de Araujo AS, Emery FS, dos Santos MR, de Simone CA, Menna-Barreto RF, de Castro SL.
    Eur J Med Chem; 2012 Jun 10; 52():304-12. PubMed ID: 22483633
    [Abstract] [Full Text] [Related]

  • 34. In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea.
    Veiga-Santos P, Pelizzaro-Rocha KJ, Santos AO, Ueda-Nakamura T, Dias Filho BP, Silva SO, Sudatti DB, Bianco EM, Pereira RC, Nakamura CV.
    Parasitology; 2010 Sep 10; 137(11):1661-70. PubMed ID: 20546638
    [Abstract] [Full Text] [Related]

  • 35. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM, Leite AC, de Oliveira BG, Moreira DR, Lima MS, Soares MB, Leite LF.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6682-91. PubMed ID: 19683450
    [Abstract] [Full Text] [Related]

  • 36. New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies.
    Aguirre G, Boiani M, Cabrera E, Cerecetto H, Di Maio R, González M, Denicola A, Sant'anna CM, Barreiro EJ.
    Eur J Med Chem; 2006 Apr 15; 41(4):457-66. PubMed ID: 16497414
    [Abstract] [Full Text] [Related]

  • 37. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms.
    Eufrásio AG, Cordeiro AT.
    Methods Mol Biol; 2020 Apr 15; 2116():773-780. PubMed ID: 32221954
    [Abstract] [Full Text] [Related]

  • 38. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
    Boiani L, Aguirre G, González M, Cerecetto H, Chidichimo A, Cazzulo JJ, Bertinaria M, Guglielmo S.
    Bioorg Med Chem; 2008 Sep 01; 16(17):7900-7. PubMed ID: 18706821
    [Abstract] [Full Text] [Related]

  • 39. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
    Caterina MC, Perillo IA, Boiani L, Pezaroglo H, Cerecetto H, González M, Salerno A.
    Bioorg Med Chem; 2008 Mar 01; 16(5):2226-34. PubMed ID: 18083035
    [Abstract] [Full Text] [Related]

  • 40. Cytotoxic, mutagenic and genotoxic evaluation of crude extracts and fractions from Piper jericoense with trypanocidal action.
    Hamedt AL, Ortiz IC, García-Huertas PA, Sáenz J, de Araujo AC, De Mattos JC, Rodríguez-Gazquez MA, Triana-Chávez O.
    Acta Trop; 2014 Mar 01; 131():92-7. PubMed ID: 24361641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.